MCA
IBB icon

Magnolia Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Magnolia Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$606K Hold
3,588
– – 0.12% 186
2025
Q4 		$606K Buy
+3,588
New +$583K 0.13% 157
2025
Q3 		– Sell
-3,725
Closed -$471K – 240
2025
Q2 		$471K Hold
3,725
– – 0.12% 162
2025
Q1 		$476K Hold
3,725
– – 0.13% 156
2024
Q4 		$492K Buy
3,725
+478
+15% +$67.2K 0.13% 159
2024
Q3 		$473K Buy
+3,247
New +$470K 0.24% 97

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Magnolia Capital Advisors's IBB Position: Q1 2026 in Review

Magnolia Capital Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 3,588 shares worth $606K. The position accounts for 0.12% of the portfolio, ranked #186.

Magnolia Capital Advisors first reported a position in IBB in Q3 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Magnolia Capital Advisors held 3,588 shares of iShares Biotechnology ETF worth $606K as of Q1 2026.
  • Magnolia Capital Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.12% of Magnolia Capital Advisors's portfolio in Q1 2026, its #186 holding.
  • Magnolia Capital Advisors first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 6 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.